Recs

8

Political Theater: More Entertaining Than Helpful

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Viewers could enjoy some nice political theater during yesterday's seven-plus hour bipartisan health-care conference -- including a little campaign-flashback debate between President Obama and Sen. John McCain -- but as you might expect, nothing much came of the daylong event.

The two sides are just too far apart on their solutions for how to decrease health-care costs and increase the number of insured individuals.

What they could agree on
Democrats acknowledged that setting limits on malpractice suits has the potential to save some money, although how much it'll save is still up for debate.

Republicans seem willing to back Democrats' health exchanges as an alternative to a government-sponsored public plan. The exchanges will likely cut into health insurers' margins, but insurers might be able to compensate with increased volume.

Both sides would like to see Americans with preexisting conditions get insurance, but they differ on the most effective way to solve the problem. Democrats want a mandate requiring everyone to carry coverage, to help dilute the higher costs incurred by individuals with pre-existing conditions. Republicans would rather see those with preexisting conditions put in a separate pool, to avoid forcing people to carry health insurance coverage.

That's not enough to get things done
Unfortunately, everything in our health-care system is tied together, and a partial solution won't do much. It's too expensive to help fund insurance for the tens of millions of uninsured Americans if we can't also create corresponding cost cuts. The easiest way to decrease the cost is to get that large pool of younger, healthier, currently uninsured people to enter the system. You really can't have one without the other.

Some of the cuts, like encouraging comparative medicine to get the best bang for the buck, are possible on their own. Perhaps that's the solution to get the ball rolling: Start by passing saving measures that might decrease costs slightly, and then give health-care reform another stab when it seems more politically feasible.

Limbo should be a four letter word
The eternal health-care debate causes problems for investors, because the stock market doesn't like uncertainty. The betas -- a measure of volatility -- on most health insurers are higher than they have been historically.

Company

Average Beta Over
Last 5 Years

Average Beta Over
Last 2 Years

Average Beta Over
Last Year

WellPoint (NYSE: WLP  )

1.038

1.059

1.135

UnitedHealth Group (NYSE: UNH  )

1.026

1.316

1.376

Aetna (NYSE: AET  )

1.270

1.173

1.436

Humana

1.215

1.134

1.579

Cigna

1.826

1.539

1.666

Average

1.275

1.243

1.438

Source: Capital IQ, a division of Standard & Poor's.

Many pharmaceutical companies haven't seen their betas increase, but they also haven’t participated in the recent rally, either:

Company

1-Year Increase

Eli Lilly (NYSE: LLY  )

10.3%

Abbott Labs (NYSE: ABT  )

7.0%

Johnson & Johnson (NYSE: JNJ  )

20.7%

Pfizer (NYSE: PFE  )

39.3%

S&P500

46.4%

Source: Capital IQ, a division of Standard & Poor's.

Pfizer looks like it came along for most of the ride, but I'd say its increase has more to do with investors' increased confidence in its Wyeth purchase than some fundamental rise in the prospects for the company's growth. In fact, the stock sits about where it was at the beginning of 2009, before the acquisition announcement, while the S&P 500 is up 18%.

Reaching a conclusion on health-care reform, whether a bill gets passed or not, should help calm things down. Then stocks can once again trade on the potential of their future profits, rather than relying on investors' guesses about the outcome of reform.

Does that mean there's a buying opportunity? Only if you think this marathon will end. The President gave a deadline of a month to six weeks to work out a bipartisan proposal before Democrats proceed on their own. But the option for getting such a bill through the Senate, a process called reconciliation that only requires a simple majority, might be more politically risky than some Democrats are willing to partake in.

Stay tuned, Fools. Unfortunately, this political theater is far from over.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Pfizer, UnitedHealth, and WellPoint are Motley Fool Inside Value picks. UnitedHealth is also a Stock Advisor selection and the Fool owns some shares. Johnson & Johnson is an Income Investor pick and Motley Fool Options has recommended buying calls on the shares. Try any of our Foolish newsletter services free for 30 days.

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 26, 2010, at 5:17 PM, PositiveMojo wrote:

    I think you are right on - the market does not like uncertainty and neither do I.

  • Report this Comment On February 28, 2010, at 11:07 PM, georcole wrote:

    I just read an article saying that Obama is very strongly considering reconciliation. If they do that, I will vote all Republican in the mid-term elections. I believe that the Independents tend to be the better picks, but I would vote Republican, as they stand a better chance of winning than the Independents do, to make sure that we get the Democrats out. I agree that we need some kind of reform, I just don't agree with most of the features that the current plans include. I think that this plan http://www.fool.com/investing/general/2010/02/24/dear-presid... has a lot more merit than what Congress is looking at.

    George

  • Report this Comment On March 01, 2010, at 2:35 AM, jomueller1 wrote:

    It was a sad show. I feel sorry for this country having all those selfish actors talk about issues until they die (the issues, not the politicians though the latter would be better). In the meantime the problems get worse and nothing gets done. What loyalty do those actors have? May be they are loyal to their bank accounts.

    Why is the president not asking the congress members the one question: "Why do you want a class system in health care and not have everyone enjoy the same kind of care that the congress members have?" or "Are congress members superior human beings who deserve a superior health care?".

    I am against reconciliation because that is a euphemism for Republicans being a minority and still get it their way. Is that democratic? I do not want hand-outs but affordability and security for everyone.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1122662, ~/Articles/ArticleHandler.aspx, 5/25/2012 9:56:19 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 40 minutes ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:00 PM
PFE $22.13 Down -0.01 -0.05%
Pfizer, Inc. CAPS Rating: ****
UNH $56.12 Down -0.10 -0.18%
UnitedHealth Group CAPS Rating: *****
WLP $67.90 Up +0.08 +0.12%
WellPoint, Inc. CAPS Rating: *****
LLY $41.11 Down -0.05 -0.12%
Eli Lilly & Co. CAPS Rating: ****
ABT $62.25 Down -0.17 -0.27%
Abbott Laboratorie… CAPS Rating: *****
AET $41.20 Up +0.07 +0.17%
Aetna, Inc. CAPS Rating: ****
JNJ $62.51 Down -0.59 -0.94%
Johnson & Johnson CAPS Rating: *****

Advertisement